CXCR4 engagement triggers CD47 internalization and antitumor immunization in a mouse model of mesothelioma
暂无分享,去创建一个
A. Carretta | M. Bianchi | V. Colantuoni | V. Basso | A. Mondino | F. Sanvito | A. Rubartelli | F. Brambilla | F. De Marchis | Maura Casalgrandi | A. Preti | P. Castellani | R. Boldorini | S. Zambrano | L. Sabatino | R. Mezzapelle | M. Crippa | C. Passera | O. Rena | Federica Colombo | Francesca Caprioglio | Manuela Leo | Riccardo Ertassi | Marco Silingardi | Samuel Zambrano
[1] M. Bianchi,et al. The Chemokine Receptor CXCR4 in Cell Proliferation and Tissue Regeneration , 2020, Frontiers in Immunology.
[2] F. Marincola,et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death , 2020, Journal for ImmunoTherapy of Cancer.
[3] Brian F. Volkman,et al. Biased antagonism of CXCR4 avoids antagonist tolerance , 2018, Science Signaling.
[4] K. Tracey,et al. Exploring the biological functional mechanism of the HMGB1/TLR4/MD-2 complex by surface plasmon resonance , 2018, Molecular Medicine.
[5] L. Zitvogel,et al. eIF2α phosphorylation is pathognomonic for immunogenic cell death , 2018, Cell Death & Differentiation.
[6] M. Bianchi,et al. High mobility group box 1 orchestrates tissue regeneration via CXCR4 , 2018, The Journal of experimental medicine.
[7] M. Bianchi,et al. High‐mobility group box 1 protein orchestrates responses to tissue damage via inflammation, innate and adaptive immunity, and tissue repair , 2017, Immunological reviews.
[8] M. Bianchi,et al. HMGB1 as biomarker and drug target. , 2016, Pharmacological research.
[9] A. Berns,et al. Human malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells , 2016, Scientific Reports.
[10] Wei Zhang,et al. CXCL12/CXCR4: a symbiotic bridge linking cancer cells and their stromal neighbors in oncogenic communication networks , 2016, Oncogene.
[11] yang-xin fu,et al. CD47 Blockade Triggers T cell-mediated Destruction of Immunogenic Tumors , 2015, Nature Medicine.
[12] S. Pastorino,et al. Aspirin delays mesothelioma growth by inhibiting HMGB1-mediated tumor progression , 2015, Cell Death and Disease.
[13] J. Violin,et al. Biased ligands at G-protein-coupled receptors: promise and progress. , 2014, Trends in pharmacological sciences.
[14] T. K. van den Berg,et al. The interaction between signal regulatory protein alpha (SIRPα) and CD47: structure, function, and therapeutic target. , 2014, Annual review of immunology.
[15] J. Aerts,et al. Tumor-associated macrophages in thoracic malignancies. , 2013, Lung cancer.
[16] Laurence Zitvogel,et al. Immunogenic cell death in cancer therapy. , 2013, Annual review of immunology.
[17] H. Pass,et al. Cancer cell secretion of the DAMP protein HMGB1 supports progression in malignant mesothelioma. , 2012, Cancer research.
[18] Jens-Peter Volkmer,et al. The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors , 2012, Proceedings of the National Academy of Sciences.
[19] Ash A. Alizadeh,et al. Therapeutic antibody targeting of CD47 eliminates human acute lymphoblastic leukemia. , 2011, Cancer research.
[20] L. You,et al. The expression of CXCR4, CXCL12 and CXCR7 in malignant pleural mesothelioma , 2011, The Journal of pathology.
[21] Ash A. Alizadeh,et al. Calreticulin Is the Dominant Pro-Phagocytic Signal on Multiple Human Cancers and Is Counterbalanced by CD47 , 2010, Science Translational Medicine.
[22] H. Pass,et al. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation , 2010, Proceedings of the National Academy of Sciences.
[23] Beverly A. Teicher,et al. CXCL12 (SDF-1)/CXCR4 Pathway in Cancer , 2010, Clinical Cancer Research.
[24] Michael Karin,et al. Inflammation and colon cancer. , 2010, Gastroenterology.
[25] I. Weissman,et al. CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis , 2009, Cell.
[26] P. van Endert,et al. Mechanisms of pre‐apoptotic calreticulin exposure in immunogenic cell death , 2009, The EMBO journal.
[27] J. Wilson,et al. Identification of the murine firefly luciferase-specific CD8 T-cell epitopes , 2009, Gene Therapy.
[28] Laurence Zitvogel,et al. Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy , 2007, Nature Medicine.
[29] U. Landegren,et al. Direct observation of individual endogenous protein complexes in situ by proximity ligation , 2006, Nature Methods.
[30] S. Müller,et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells , 2004, EMBO reports.
[31] E. Ingulli,et al. Cd47 (Integrin-Associated Protein) Engagement of Dendritic Cell and Macrophage Counterreceptors Is Required to Prevent the Clearance of Donor Lymphohematopoietic Cells , 2001, The Journal of experimental medicine.
[32] R. China,et al. The CD 47-signal regulatory protein alpha ( SIRPa ) interaction is a therapeutic target for human solid tumors , 2012 .